Literature DB >> 14692228

Neoplastic disease and deletion 22q11.2: a multicentric study and report of two cases.

Anna Scattone1, Gilda Caruso, Andrea Marzullo, Domenico Piscitelli, Mattia Gentile, Lucia Bonadonna, Giuseppe Balducci, Maria Cristina Digilio, Alessandro Jenkner, Francesca Diomedi Camassei, Renata Boldrini, Pietro Nazzaro, Lucio Pollice, Gabriella Serio.   

Abstract

Deletion 22q11.2 is a chromosomal abnormality detected in young patients with clinical manifestations of the DiGeorge/velocardiofacial syndrome. Conotruncal heart defects are also associated with del22q11.2. An association of these cardiac malformations with neoplasias has been observed. Our series includes two cases of malignancies, a hepatoblastoma and a renal-cell carcinoma, arising in children with complex cardiac malformations. The aim of the study was to determine if the deletion at 22q11.2 was present and could be responsible for both pathological processes. Del22q11.2 was identified in both cases. Comparative genomic hybridization revealed terminal gains on chromosomes 1q and Xq and terminal loss on 1p in the hepatoblastoma, and gains in 1p, 12q, 16p, 20q, 22q, and whole chromosome 19 and loss of Xq in the renal-cell carcinoma. Our results confirm a common genetic basis for cardiac malformations, and del22q11.2 presents a risk factor for the development of pediatric tumours.

Entities:  

Mesh:

Year:  2003        PMID: 14692228     DOI: 10.1080/pdp.22.4.323.341

Source DB:  PubMed          Journal:  Pediatr Pathol Mol Med        ISSN: 1522-7952


  3 in total

1.  Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndrome.

Authors:  Jeffrey C Murray; David J Donahue; Saleem I Malik; Yvette B Dzurik; Emily Z Braly; Margaret J Dougherty; Katherine W Eaton; Jaclyn A Biegel
Journal:  J Neurooncol       Date:  2010-08-21       Impact factor: 4.130

2.  Risk of malignancy in 22q11.2 deletion syndrome.

Authors:  Toer Stevens; Jutte van der Werff Ten Bosch; Marjan De Rademaeker; Ann Van Den Bogaert; Machiel van den Akker
Journal:  Clin Case Rep       Date:  2017-03-02

Review 3.  Hepatoblastoma in molecularly defined, congenital diseases.

Authors:  Gunther Nussbaumer; Martin Benesch
Journal:  Am J Med Genet A       Date:  2022-04-28       Impact factor: 2.578

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.